{
  "id": 14839686,
  "title": "Nurix Therapeutics CSO Gwenn Hansen sells $36,300 in common stock",
  "url": "https://urgent.news/2026/10/16/nurix-therapeutics-cso-gwenn-hansen-sells-36-300-in-common-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T01:16:25.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/nurix-therapeutics-cso-gwenn-hansen-sells-36300-in-common-stock-93CH-4952936"
  },
  "original_language": "en",
  "account": "Nurix Therapeutics' Chief Scientific Officer, Gwenn Hansen, sold 1,452 shares of the company's common stock on October 15, 2026, for a total of $36,300. This sale was executed in accordance with a pre-approved Rule 10b5-1 trading plan. The shares were sold at a rate of $25.00 per share, following the exercise of employee stock options. Post-sale, Hansen currently owns 117,227 shares of Nurix Therapeutics common stock.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Oruka Therapeutics CMO Joana Goncalves sells $523,647 in stock",
        "url": "https://urgent.news/2026/10/15/oruka-therapeutics-cmo-joana-goncalves-sells-523-647-in-stock",
        "published": "2026-10-15T22:46:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}